Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malaria: Probably locally acquired in Toronto, Ontario.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Travellers from the tropics-a practical approach to common problems.

Canadian family physician Medecin de famille canadien·2011
Same author

Infections in refugee children from developing countries.

Canadian family physician Medecin de famille canadien·2011
Same author

Exchange transfusion in a case of severe Plasmodium falciparum infection: a case report.

Canadian family physician Medecin de famille canadien·2011
Same author

Can one afford not to screen for parasites in high-risk immigrant populations?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2007
Same author

The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada.

Journal of immigrant and minority health·2006

Related Experiment Video

Updated: Jun 19, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 15, 2014

Mebendazole.

J S Keystone, J K Murdoch

    Annals of Internal Medicine
    |October 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Mebendazole is a safe and effective anthelmintic, particularly for trichuriasis, enterobiasis, and hookworm infections. Its unique mechanism of microtubular destruction shows promise for treating multiple helminth infections.

    Keywords:
    Clinical ResearchDiseasesEconomic FactorsHealthParasite ControlParasitic DiseasesPublic HealthResearch And DevelopmentResearch MethodologyTechnologyTreatment

    More Related Videos

    Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
    08:12

    Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

    Published on: October 5, 2020

    Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays
    05:19

    Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

    Published on: August 1, 2025

    Related Experiment Videos

    Last Updated: Jun 19, 2026

    Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
    06:49

    Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

    Published on: March 15, 2014

    Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
    08:12

    Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

    Published on: October 5, 2020

    Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays
    05:19

    Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

    Published on: August 1, 2025

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Parasitology

    Background:

    • Mebendazole is an anthelmintic with a broad spectrum of activity and a favorable safety profile.
    • Clinical experience over five years highlights its unique characteristics.

    Purpose of the Study:

    • To review the efficacy and safety of mebendazole as an anthelmintic.
    • To discuss its mechanism of action and clinical applications.

    Main Methods:

    • Review of clinical data and scientific literature on mebendazole.
    • Analysis of its mechanism of action (microtubular destruction) and glucose uptake inhibition in parasites.

    Main Results:

    • Mebendazole is effective for trichuriasis, enterobiasis, and hookworm infections.
    • Poor absorption generally does not limit efficacy, except possibly in systemic infections.
    • Shows promise for capillariasis and hydatid disease, with further research needed for other helminthiases.

    Conclusions:

    • Mebendazole is a valuable anthelmintic, especially for common infections and potentially for multiple helminth infections.
    • Its unique mechanism and safety profile support its continued use and exploration in new applications.